Morphology and Distribution of TDP-43 Pre-inclusions in Primary Progressive Aphasia.
Frontotemporal dementia
Frontotemporal lobar degeneration
Neurodegeneration
Primary progressive aphasia
Proteinopathies
TDP-43
Journal
Journal of neuropathology and experimental neurology
ISSN: 1554-6578
Titre abrégé: J Neuropathol Exp Neurol
Pays: England
ID NLM: 2985192R
Informations de publication
Date de publication:
01 03 2019
01 03 2019
Historique:
pubmed:
13
2
2019
medline:
12
6
2020
entrez:
13
2
2019
Statut:
ppublish
Résumé
Diffusely stained phosphorylated 43-kDa TAR DNA-binding protein (TDP-43)-positive "pre-inclusions" have been described. This experiment investigated morphological subtypes of pre-inclusions and their relationship with TDP-43 inclusions in primary progressive aphasia (PPA), a dementia characterized by gradual dissolution of language. Brain sections from 5 PPA participants with postmortem diagnoses of frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) were immunohistochemically stained using an antibody to phosphorylated TDP-43 and quantitatively examined for regional and hemispheric distribution using unbiased stereology. Cortical TDP-43 pre-inclusions included smooth, granular/dot-like, or fibrillar staining with localization to the nucleus, cytoplasm, or both. Mature and pre-inclusions were quantified in a region with high and a region with low mature inclusion density, and contralateral homologs. Regions with lower mature inclusions were characterized by higher densities of pre-inclusions, while increasing burden of inclusions corresponded to lower densities of pre-inclusions (p < 0.05). Mature inclusions showed significant asymmetry that favored the language-dominant hemisphere (p < 0.01), while pre-inclusions displayed the opposite pattern (p < 0.01). Granular-type pre-inclusions were more abundant (p < 0.05) and drove the hemispheric and regional differences (p < 0.02). These results suggest that pre-inclusions are present in greater abundance prior to the formation of mature TDP-43 inclusions, and appear to develop through progressive stages into mature intracytoplasmic, or intranuclear aggregates.
Identifiants
pubmed: 30753613
pii: 5310269
doi: 10.1093/jnen/nlz005
pmc: PMC6380320
doi:
Substances chimiques
DNA-Binding Proteins
0
TARDBP protein, human
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
229-237Subventions
Organisme : NIA NIH HHS
ID : P30 AG013854
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC008552
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS085770
Pays : United States
Informations de copyright
© 2019 American Association of Neuropathologists, Inc. All rights reserved.
Références
J Neurosci. 2010 Jan 13;30(2):639-49
pubmed: 20071528
J Phys Chem Lett. 2015 Jul 2;6(13):2608-15
pubmed: 26266742
Neurology. 2005 Feb 8;64(3):556-7
pubmed: 15699397
Neuron. 2013 Aug 7;79(3):416-38
pubmed: 23931993
Acta Neuropathol. 2014 Mar;127(3):423-439
pubmed: 24407427
Ann Neurol. 2001 Apr;49(4):425-32
pubmed: 11310619
Mol Neurodegener. 2011 Oct 26;6:73
pubmed: 22029574
J Biol Chem. 2009 Oct 2;284(40):27416-24
pubmed: 19651785
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
Neurology. 2016 Feb 16;86(7):627-36
pubmed: 26791154
EBioMedicine. 2016 Apr;6:42-49
pubmed: 27211547
Ann Neurol. 1982 Jun;11(6):592-8
pubmed: 7114808
Nat Med. 1998 Jul;4(7):827-31
pubmed: 9662375
J Biol Chem. 2009 Jul 24;284(30):20329-39
pubmed: 19465477
Acta Neuropathol. 2017 Jul;134(1):79-96
pubmed: 28466142
Acta Neuropathol. 2013 Jan;125(1):121-31
pubmed: 23124365
J Biol Chem. 2009 Mar 27;284(13):8516-24
pubmed: 19164285
Ann Neurol. 2010 Aug;68(2):220-30
pubmed: 20641005
Nat Struct Mol Biol. 2018 Apr;25(4):311-319
pubmed: 29531287
Hum Mol Genet. 2014 Feb 15;23(4):1025-35
pubmed: 24105464
Neuropathology. 2010 Apr;30(2):103-12
pubmed: 20102519
J Virol. 1995 Jun;69(6):3584-96
pubmed: 7745706
Neurology. 2010 May 18;74(20):1607-10
pubmed: 20479359
Brain. 2014 Apr;137(Pt 4):1176-92
pubmed: 24574501
J Mol Neurosci. 2011 Nov;45(3):390-401
pubmed: 21607722
Acta Neuropathol. 2012 Sep;124(3):373-82
pubmed: 22878865
Acta Neuropathol. 2008 Jan;115(1):123-31
pubmed: 18004574
Nat Rev Neurosci. 2011 Nov 30;13(1):38-50
pubmed: 22127299
Acta Neuropathol. 2008 Aug;116(2):193-203
pubmed: 18560845
Neurobiol Aging. 2003 Oct;24(6):767-76
pubmed: 12927759
Acta Neuropathol. 2006 Oct;112(4):389-404
pubmed: 16906426
Acta Neuropathol. 2012 Jun;123(6):807-23
pubmed: 22539017
Acta Neuropathol. 2013 Mar;125(3):463-5
pubmed: 23378033
Acta Neuropathol. 2007 Jul;114(1):5-22
pubmed: 17579875
Acta Neuropathol. 2010 Jan;119(1):1-4
pubmed: 19924424
Acta Neuropathol. 2011 Jul;122(1):111-3
pubmed: 21644037
J Neurosci. 2010 Aug 11;30(32):10851-9
pubmed: 20702714
Neurology. 2018 Jan 30;90(5):e396-e403
pubmed: 29305438